“showed a trend”

Furthermore, a < 90% unilateral predominance of interictal spikes showed a trend for worse outcomes (OR = 3.86, 95% CI = .94–15.8, p = .06).

In the goal implementation phase, the physical activity group showed a trend toward higher accuracy than the inactive group [ t (27) = 15.33, p = 0.06; inactive: mean = 61%, SD = 8%; physical activity: mean = 66%, SD = 3%].

Result Pretreatment prior to lysis showed a trend toward improving DNA extraction efficiency (paired t-test, P = 0.06; Fig 1A ).

At 12 months, EK2 scores showed a trend toward improvement in swallowing [item 16] ( p = 0.06), peak flow increased significantly (244 ± 112 vs. 259 ± 124 L/min, p = 0.036), and there was a trend toward decreased NFL levels (11.4 ± 4.9 vs. 9.4 ± 2.7 pg/mL, p = 0.093).

Animals resuscitated with plasma showed a trend towards lower syndecan-1 levels compared to the standard-volume crystalloid group (82 vs 99 ng/mL, p = 0.06) and had lower levels of VCAM-1 (424 vs 592 ng/mL, p < 0.01) compared to the standard volume crystalloid group, but not when compared to the low-volume crystalloid group.

Overall, TTSE showed a trend toward an increased DMI compared with the colonoscope alone (difference = 13.61; 95% confidence interval, −3.12 to 30.34; P = .06).

Cirrhotic patients showed a trend toward increased perioperative transfusion (19% vs. 0%, p = 0.06) and postoperative ICU admission (28.6% vs. 11.8%, p = 0.21).

RFIP-nha WT showed a trend in AIM2 upregulation (p = 0.06).

Similar trends were found for the CNR values—the iliac station showed a trend of lower values compared to tibial ( p = 0.06), while the iliac vs. femoral ( p = 0.28) or femoral vs. tibial ( p = 1.00) stations did not show significant differences.

However, the post hoc comparisons only showed a trend towards a difference between the DHM animals and the control group (Tukey HSD, p = 0.060; Table S2 ).

This group also showed a trend toward improved OS in the multivariable analyses (HR=0.80, 95% CI 0.64 to 1.00, p=0.06, figure 3F , online supplemental tables 18 and 21 ).

Notably, GGT showed a trend favoring SGLT2i with a borderline p-value ( P = 0.06 in the anti-diabetic drug subgroup), while FBG reduction lacked statistical significance.

Cellular deconvolution analysis showed a trend toward an increase in smooth muscle cells in the EAT of patients with AF, albeit not significant ( P = 0.06) (Extended Data Fig. 3f,g ).

While sufficient material was available in only a small number of cases, western blot analysis of protein extracts from affected ( n = 4) and control cases ( n = 3) showed a trend toward reduced WNT10A expression in keratoconus patients (ratio: 0.07, P = 0.06; Figs. 2 B, 2 C).

Diazepam-treated HAB mice showed a trend to a reduction in the number of vocalizing animals compared to vehicle-treated HAB mice ( χ 2 = 3.55, p = 0.06; Figure 3 A), with the number of emitted sonic calls significantly decreased ( U = 31.5, p < 0.05; Figure 3 B).

In contrast, blood glutamate (Glu) levels showed a trend towards an increase in the dapagliflozin group compared with the insulin group (p = 0.06). 3.3.

At 90 days, CC-EEPFS showed a trend towards lower late lumen loss compared to SS-SEPBS (see supplementary Table 7 , p = 0.06).

Kaplan-Meier analysis showed a trend toward earlier fever in FQRE-positive patients (HR: 1.59, 95% CI: 0.98–2.59, p = 0.06) (Fig. 1 b).

Several proinflammatory cytokines, such as Il1β, Il1α, Tnfα, Cd86, IL6, and Trem2, were significantly upregulated by SE, but no changes were induced by the CQ treatment except for Il6 and Trem2 , which showed a trend to increase ( p = .06) in CQ compared to VHC treatment (Table S1 ).

This interaction showed a trend level association in the ADNI-1 group ( t = 1.82, unadjusted p = 0.06) and a very significant association in the combined dataset ( t = 4.42, unadjusted p = 1.1 × 10 −5 ).

While bloodletting showed a trend toward greater improvement than drug therapy, the difference was nonsignificant (MD = −0.04; 95% CI: [−0.08, 0.00]; p = 0.06; Figure 14 ), with no heterogeneity ( I 2 = 0%, p = 0.94). 3.10.

5.45 months, p = 0.225), while patients who required dose reductions due to adverse events showed a trend toward longer OS compared with those without dose reduction (5.45 vs. 2.92 months, p = 0.060), although not statistically significant.

Animals receiving the DP diet showed a trend ( p = 0.06) toward increased TbTh in the distal femoral metaphysis at 12 weeks, but there were no statistically significant improvements in TbTh in the distal femur or vertebral body at either time point.

Although not statistically significant, patients with recurrent disease showed a trend toward longer OS and PFS than those with unresectable disease (OS, p = 0.06; PFS, p = 0.05) ( Figure 2 ).

Post hoc analysis showed a trend toward increased absolute weight in resilient and susceptible animals relative to controls (p = 0.06 and p = 0.08, respectively).